XJSE
PBG
Market cap37mUSD
Dec 05, Last price
676.00ZAR
Name
PBT Group Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
PBT Group Limited, alongside its diverse subsidiaries, delivers highly specialized consulting expertise to a wide array of sectors, including financial services, insurance, medical healthcare, retail, and telecommunications. Its operational footprint covers South Africa, Europe, Australia, and the United Kingdom. The company's offerings encompass strategic guidance, advanced data engineering, intuitive data visualization, cutting-edge artificial intelligence solutions, custom application development, and comprehensive managed services. PBT Group also provides distinct healthcare management solutions specifically for medical aid and managed care providers. These include real-time claims processing, sophisticated query capabilities, electronic data interchange, robust document management, membership and contribution administration, and medical savings account oversight. Additionally, the group excels in providing business intelligence and in-depth data analytics services. Furthermore, PBT Group develops bespoke software systems and digital platforms for web and mobile, handling the complete project lifecycle from business analysis and software architecture to full-scale development. Founded in 1998 as Prescient Limited before its rebranding, the company maintains its headquarters in Cape Town, South Africa.
Valuation
Title ZAR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||